# Recombinant Protein & VLP Vaccines Sector

Canonical URL: https://biopharmsignal.com/sector/recombinant-protein-vlp-vaccines

Recombinant Protein & VLP Vaccines includes companies developing vaccines built from recombinant antigens or virus-like particles. These approaches often aim to improve immunogenicity, safety, or manufacturability compared with older vaccine formats.

Companies currently grouped under Recombinant Protein & VLP Vaccines: 2

## Recent Sector News

- 2021-03-08 23:00 EST — NVAX — [Novavax to Participate in H.C. Wainwright Virtual Global Life Sciences Conference Fireside Chat](https://biopharmsignal.com/news/NVAX/novavax-to-participate-in-h-c-wainwright-virtual-global-life-sciences-conference-089716a7) — Source: Novavax
- 2021-03-01 21:02 EST — NVAX — [Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights](https://biopharmsignal.com/news/NVAX/novavax-reports-fourth-quarter-and-full-year-2020-financial-results-and-operatio-7ef9cc50) — Source: Novavax
- 2021-03-01 12:11 EST — NVAX — [ノヴァヴァックスと武田がノヴァヴァックスのCOVID-19ワクチン候補のライセンス契約を確定し、武田は日本で第I/Ⅱ相試験を開始](https://biopharmsignal.com/news/NVAX/covid-19-i-3c85a346) — Source: Novavax
- 2021-02-26 13:23 EST — NVAX — [Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan](https://biopharmsignal.com/news/NVAX/novavax-and-takeda-finalize-license-agreement-for-novavax-covid-19-vaccine-candi-edc7c5fc) — Source: Novavax
- 2021-02-22 12:00 EST — NVAX — [Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico](https://biopharmsignal.com/news/NVAX/novavax-completes-enrollment-of-prevent-19-covid-19-vaccine-pivotal-phase-3-tria-ee0f3d1d) — Source: Novavax
- 2021-02-18 21:02 EST — NVAX — [Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine](https://biopharmsignal.com/news/NVAX/novavax-announces-memorandum-of-understanding-with-gavi-for-cumulative-supply-to-cf2d04fe) — Source: Novavax
- 2021-02-16 13:00 EST — NVAX — [Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results and Operational Highlights on March 1, 2021](https://biopharmsignal.com/news/NVAX/novavax-to-host-conference-call-to-discuss-fourth-quarter-financial-results-and--48a27ec3) — Source: Novavax
- 2021-02-16 01:04 EST — NVAX — [Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea](https://biopharmsignal.com/news/NVAX/novavax-announces-expanded-collaboration-and-license-agreement-with-sk-bioscienc-08f5e151) — Source: Novavax
- 2021-02-04 22:05 EST — NVAX — [Novavax und die Regierung der Schweiz geben eine Grundsatzvereinbarung zur Bereitstellung des COVID-19-Impfstoffes bekannt](https://biopharmsignal.com/news/NVAX/novavax-und-die-regierung-der-schweiz-geben-eine-grundsatzvereinbarung-zur-berei-3726d81c) — Source: Novavax
- 2021-02-04 21:05 EST — NVAX — [Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization](https://biopharmsignal.com/news/NVAX/novavax-announces-start-of-rolling-review-by-multiple-regulatory-authorities-for-735c7444) — Source: Novavax
- 2021-02-04 02:14 EST — NVAX — [Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine](https://biopharmsignal.com/news/NVAX/novavax-and-government-of-switzerland-announce-agreement-in-principle-to-supply--ba4f929e) — Source: Novavax
- 2021-02-02 17:31 EST — NVAX — [Novavax Announces Memorandum of Understanding to Produce COVID-19 Vaccine Made in Canada](https://biopharmsignal.com/news/NVAX/novavax-announces-memorandum-of-understanding-to-produce-covid-19-vaccine-made-i-40caaa4b) — Source: Novavax
- 2021-02-02 00:32 EST — NVAX — [Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science](https://biopharmsignal.com/news/NVAX/novavax-to-present-covid-19-vaccine-candidate-data-at-new-york-academy-of-scienc-bc719da0) — Source: Novavax
- 2021-01-28 21:05 EST — NVAX — [Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial](https://biopharmsignal.com/news/NVAX/novavax-covid-19-vaccine-demonstrates-89-3-efficacy-in-uk-phase-3-trial-e313b3b1) — Source: Novavax
- 2021-01-22 22:23 EST — NVAX — [Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine](https://biopharmsignal.com/news/NVAX/novavax-and-government-of-canada-finalize-advance-purchase-agreement-for-covid-1-44f6dcd6) — Source: Novavax
- 2021-01-22 21:49 EST — NVAX — [Novavax Names Madelyn Caltabiano Senior Vice President, Global Program Management](https://biopharmsignal.com/news/NVAX/novavax-names-madelyn-caltabiano-senior-vice-president-global-program-management-fb93f99c) — Source: Novavax
- 2021-01-15 13:00 EST — NVAX — [Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax  Chief Regulatory and Quality Officer](https://biopharmsignal.com/news/NVAX/regulatory-expert-henrietta-ukwu-m-d-appointed-novavax-chief-regulatory-and-qual-a3c035a8) — Source: Novavax
- 2021-01-07 23:14 EST — NVAX — [Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine](https://biopharmsignal.com/news/NVAX/novavax-finalizes-agreement-with-commonwealth-of-australia-for-51-million-doses--1de1e935) — Source: Novavax
- 2021-01-06 14:00 EST — NVAX — [Novavax to Participate in Upcoming Conferences](https://biopharmsignal.com/news/NVAX/novavax-to-participate-in-upcoming-conferences-a5144ea3) — Source: Novavax
- 2020-12-28 14:21 EST — NVAX — [Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico](https://biopharmsignal.com/news/NVAX/novavax-announces-initiation-of-prevent-19-pivotal-phase-3-efficacy-trial-of-cov-9c77d4d3) — Source: Novavax

## Companies

- [BAVN](https://biopharmsignal.com/company/BAVN) — Bavarian Nordic
- [NVAX](https://biopharmsignal.com/company/NVAX) — Novavax